Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acarbose/Metformin Fixed Dose Combination: Treatment Patterns and Outcomes in Newly Diagnosed T2DM Patients in India

NCT04665570 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04665570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04665570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acarbose/Metformin Fixed Dose Combination: Treatment Patterns and Outcomes in Newly Diagnosed T2DM Patients in India
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
December 21, 2020
Completion date
September 5, 2024
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus